XML 23 R11.htm IDEA: XBRL DOCUMENT v3.25.3
RESTRUCTURING ACTIVITIES AND IMPAIRMENT CHARGES
 9 Months Ended
Sep. 30, 2025
Restructuring and Related Activities [Abstract]  
RESTRUCTURING ACTIVITIES AND IMPAIRMENT CHARGES RESTRUCTURING ACTIVITIES AND IMPAIRMENT CHARGES
    Invigorate Program

    The Company is engaged in a multi-year program called Invigorate, which includes structured plans to drive savings and improve productivity across the value chain, including in such areas as patient services, logistics and laboratory operations, revenue services, information technology and procurement. The Invigorate program aims to deliver 3% annual cost savings and productivity improvements to partially offset pressures from the current inflationary environment, including labor and benefit cost increases and reimbursement pressures. The Company is leveraging automation and artificial intelligence to improve productivity and also improve quality across the entire value chain, not just in the laboratory. Other areas of focus include reducing denials and patient concessions, enhancing the digital experience, and selecting and retaining talent.

    Restructuring and Impairment Charges
    
    The following table provides a summary of the Company's pre-tax restructuring and impairment charges for the three and nine months ended September 30, 2025 and 2024:
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Employee separation costs$6 $7 $18 $21 
Asset impairment charges5 — 29 — 
Total restructuring and impairment charges$11 $7 $47 $21 
    The Company's pre-tax restructuring charges for the three and nine months ended September 30, 2025 included $6 million and $18 million, respectively, of employee separation costs associated with various workforce reduction initiatives as the Company continued to restructure its organization. Additionally, during the three and nine months ended September 30, 2025, the Company recorded impairment charges of $5 million and $29 million, respectively, on certain long-lived assets related to the exit of a business. Of the total restructuring and impairment charges incurred during the three months ended September 30, 2025, $2 million, $4 million and $5 million were recorded in cost of services, selling, general and administrative expenses and other operating expense, net, respectively. Of the total restructuring and impairment charges incurred during the nine months ended September 30, 2025, $8 million, $10 million and $29 million were recorded in cost of services, selling, general and administrative expenses, and other operating expense, net, respectively.

    The Company's pre-tax restructuring charges for the three and nine months ended September 30, 2024 were $7 million and $21 million, respectively, entirely related to employee separation costs associated with various workforce reduction initiatives as the Company continued to restructure its organization. Of the total restructuring charges incurred during the three months ended September 30, 2024, $4 million and $3 million were recorded in cost of services and selling, general and administrative expenses, respectively. Of the total restructuring charges incurred during the nine months ended September 30, 2024, $12 million and $9 million were recorded in cost of services and selling, general and administrative expenses, respectively.
    
    Charges for all periods presented were primarily recorded in the Company's DIS business.

    The restructuring liability as of September 30, 2025 and December 31, 2024, which is included in accounts payable and accrued expenses, was $14 million and $13 million, respectively.